Hydroxyzine Hydrochloride Injection
» Hydroxyzine Hydrochloride Injection is a sterile solution of Hydroxyzine Hydrochloride in Water for Injection. It contains not less than 90.0 percent and not more than 110.0 percent of the labeled amount of hydroxyzine hydrochloride (C21H27ClN2O2·2HCl).
Packaging and storage Preserve in single-dose or multiple-dose containers, protected from light.
USP Reference standards 11
USP Endotoxin RS
Identification Dilute a volume of Injection with 0.1 N hydrochloric acid to obtain a solution having a concentration of about 20 µg of hydroxyzine hydrochloride per mL: the UV absorption spectrum of this solution exhibits maxima and minima at the same wavelengths as that of a 1 in 50,000 solution of USP Hydroxyzine Hydrochloride RS in 0.1 N hydrochloric acid, concomitantly measured.
Bacterial endotoxins 85 It contains not more than 3.6 USP Endotoxin Units per mg of hydroxyzine hydrochloride.
pH 791: between 3.5 and 6.0.
Other requirements It meets the requirements under Injections 1.
Assay and limit of 4-chlorobenzophenone
Mobile phase Adjust about 1000 mL of Buffer No. 1 (see Phosphate Buffers and Other Solutions in the section Media and Diluents, under AntibioticsMicrobial Assays 81) with 10 N potassium hydroxide to a pH of 6.6. To about 35 volumes of this solution add about 65 volumes of methanol, mix, and degas. Make adjustments if necessary (see System Suitability under Chromatography 621).
Standard preparation Dissolve accurately weighed quantities of USP Hydroxyzine Hydrochloride RS and 4-chlorobenzophenone in Mobile phase, and dilute quantitatively with Mobile phase to obtain a solution having known concentrations of about 250 µg of USP Hydroxyzine Hydrochloride RS and 0.5 µg of 4-chlorobenzophenone per mL. Protect this solution from light.
Assay preparation Transfer an accurately measured volume of Injection, equivalent to about 125 mg of hydroxyzine hydrochloride, to a 50-mL volumetric flask, dilute with Mobile phase to volume, and mix. Pipet 10 mL of this solution into a 100-mL volumetric flask, dilute with Mobile phase to volume, and mix. Protect this solution from light.
Chromatographic system (see Chromatography 621)The liquid chromatograph is equipped with a 254-nm detector and a 4-mm × 30-cm column that contains packing L1. The flow rate is about 2 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed under Procedure: the tailing factors for the 4-chlorobenzophenone and hydroxyzine peaks are not more than 2.5, the resolution, R, between the 4-chlorobenzophenone and hydroxyzine peaks is not less than 2.0, and the relative standard deviation for replicate injections of the Standard preparation is not more than 2.0%. The relative retention times are about 0.75 for 4-chlorobenzophenone and 1.0 for hydroxyzine.
Procedure Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of hydroxyzine hydrochloride (C21H27ClN2O2·HCl) in each mL of the Injection taken by the formula:
0.5(C / V)(rU / rS)in which C is the concentration, in µg per mL, of USP Hydroxyzine Hydrochloride RS in the Standard preparation; V is the volume, in mL, of Injection taken; and rU and rS are the hydroxyzine peak responses obtained from the Assay preparation and the Standard preparation, respectively. The ratio of the response of the 4-chlorobenzophenone peak to that of the hydroxyzine peak obtained from the Assay preparation does not exceed the corresponding ratio of peak responses obtained from the Standard preparation (0.2%).
Auxiliary Information Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 3459